Профиль компании
- Фондовый код
- ENLV
- ISIN-код
- IL0011319527
- Валюта
- US Dollar (USD)
- Дата IPO
- 1995-12-12

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular...